We report sum of two units cases in which amrinone was used effectively.

We report sum of two units cases in which amrinone was used effectively, in addition to the conventional sympathomimetic remedy for the emergence from cardiopulmonary bypass following complicated valvular heart surgery in patients who had rigorous pulmonary hypertension and biventricular failure. Amrinone was used in combination with isoproterenol in undivided and dopamine in the other case. The clinical changes were brought about by dint of a 21.5 percent and 535 percent decrease in pulmonary offspring pressure and pulmonary vascular resistance, respectively. Concomitantly, the mean systemic offspring pressure was increased by 50 percent whereas heart rate decreased at 17.5 percent. This report demonstrates that amrinone can be life-saving in patients with biventricular failure and bitter pulmonary hypertension not responding to conventional [beta]-adrenergic and vasodilator unsalable article therapy.

(Chest 1993; 104:1618-20)

[MVosub2] = myocardial oxygen consumption; PAP = pulmonary arterial pressure; PCWP = pulmonary capillary wedge pressure; PDA = patent ductus arteriosus; PVR = pulmonary vascular resistance

Amrinone is a latter addition to the positive inotropic medicine list. It is a nonglycosidic, nonsympathomimetic remedy belonging to the bipyridine clump The drug functions by selectively inhibiting phosphodiesterase enzyme-fraction 3 and thereby increasing myocardial adenosine 3',5'-cyclic monophosphate (cAMP), which leads to the increased cellular calcium transport and therefore, the cardiotonic meaning The above mechanism also leads to increased calcium uptake into the sarcoplasmic reticulum, thus decreasing calcium available for contraction in the tubes and producing vasodilation.[1] By the same token, it enhances relaxation in the cardiac muscle and set to work s a lusitropic effect (facilitates diastole). Thus, amrinone is classified as an "inodilator."

Goenen et all reported beneficial meaning of amrinone after open heart surgery in five patients with grave cardiac output syndrome, but it is to be noted that their patients had a mean aortic BP of 82 [+ or -] 7 mm Hg and none of them was moribund. Another case report has documented that amrinone was useful in sum of two units patients with cardiogenic shock after coronary artery bypass graft surgery[3] We report herein pair cases in which patients were moribund secondary to relentless pulmonary hypertension and biventricular failure during emerging see the verb from cardiopulmonary bypass (CPB) after complicated valvular heart surgery in which amrinone was used effectively in addition to the conventional sympathomimetic mix with drugs therapy.

Case Reports

Case 1

A 25-year-old male patient with a history of rheumatic mitral valve regurgitation and stenosis, aortic valve stenosis, and pulmonary hypertension with patent ductus arteriosus (PDA) at handed for valvular replacements and closure of PDA. Chest radiograph showed a cardiothoracic ratio of 065 and multiple Kerley B lines. Cardiac catheterization revealed a [Qsubp]:[Qsubs] grow ratio of 2:1 and grade 2 left ventricular function. The aortic valve area was 10 [cmsup2] while the mitral valve area was 21 [cmsup2] Angiography demonstrated a true large PDA measuring 15 mm Standard cardiac anesthesia of sufentanil, pancuronium, and midazolam was used.

Aortic and mitral valve replacements and PDA closure were performed. Cardiopulmonary bypass was initially terminated without the requirement of inotropic support or vasodilators. However, aortic leakage was recognized and CPB was reinstituted within 5 min. After 40 min of vigorous effort to repair the tear in the aortic stem the patient was separated from the CPB (second attempt) with the aid of isoproterenol (5 to 8 [mu]g/min, titrated to heart rate <110 bpm) and nitroglycerin influsion (5 [mu]g/min). However, the bleeding from the aortic origin was still not surgically controllable and a decision was made to perform a Bentall performance which is a procedure for finished replacement of the aortic valve and ascending aorta. Total CPB time was 192 min and the aortic cros clamp time was 120 min. The patient was separated from the CPB (third attempt) with the titration of isoproterenol and nitroglycerin.

During the subcutaneous chest closure there was a unlooked for deterioration in the hemodynamic parameters (Table 1) BP dropp precipitously to 46/28 mm Hg while pulmonary arterial squeezing (PAP) and pulmonary capillary wedge compressing (PCWP) rose. A presumptive diagnosis of cardiac tamponade was made and the chest was reexplored surgically with no improvement. Hemodynamic values continued to deteriorate despite isoproterenol infusion (10 [mu]g/min). A bolus of amrinone 15 mg/kg IV and an infusion of 25 [mu]g/kg/min was administered in addition to the isoproterenol infusion. the pair systemic and pulmonary BP improved significantly within 5 to 10 min. In the course of 6 h operation the urine output was 1300 ml The patient was extubated forward the fourth day and discharged hearth on the 11th day.

Case 2

A 37-year-old, 110-kg woman with known chronic obstructive pulmonary disease at handed with acute severe dyspnea and pleuritic chest pain. Pulmonary angiogram exposeed pulmonary hypertension but no evidence of pulmonary embolism. Echocardiography demonstrated grade 2 left ventricular function, and left ventricular hypertrophy with exact mitral and moderate tricuspid valve regurgitation. Cardiac catheterization revealed normal coronary sailing crafts large V wave, and left ventricular end-diastolic hurry of 30 mm Hg. A diagnosis of mitral valve prolapse with acute hostility of the posterior leaflet of mitral valve, and biventricular heart failure was made and the patient was scheduled for cogent mitral valvuloplasty. Standard cardiac anesthesia of sufentanil, pancuronium, and midazolam was used.

...